Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,470,968 papers from all fields of science
Search
Sign In
Create Free Account
Recombinant Human Adenovirus Type 5 H101
Known as:
H101
, rAd5 H101
A replication selective, recombinant, E1B and partial E3 gene deleted form of human adenovirus type 5, with potential antineoplastic activity. Upon…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Oncorine, the World First Oncolytic Virus Medicine and its Update in China.
M. Liang
Current Cancer Drug Targets
2018
Corpus ID: 3336219
The oncolytic viruses now hold a promise of new therapeutic strategy for cancer. Its concept has inspired a wave of commercial…
Expand
Highly Cited
2014
Highly Cited
2014
A simple 3,4-ethylenedioxythiophene based hole-transporting material for perovskite solar cells.
Hairong Li
,
Kunwu Fu
,
A. Hagfeldt
,
M. Grätzel
,
S. Mhaisalkar
,
A. Grimsdale
Angewandte Chemie
2014
Corpus ID: 21833523
We report a novel electron-rich molecule based on 3,4-ethylenedioxythiophene (H101). When used as the hole-transporting layer in…
Expand
Highly Cited
2008
Highly Cited
2008
Twinning–detwinning behavior during the strain-controlled low-cycle fatigue testing of a wrought magnesium alloy, ZK60A
L. Wu
,
A. Jain
,
+5 authors
P. Liaw
2008
Corpus ID: 55768935
Review
2007
Review
2007
Clinical trials with oncolytic adenovirus in China.
Wang Yu
,
H. Fang
Current Cancer Drug Targets
2007
Corpus ID: 13094650
Since the 1990s, oncolytic viruses were utilized to treat cancer patients from phase I to phase III. Oncolytic virus development…
Expand
Review
2007
Review
2007
From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development.
A. Crompton
,
D. Kirn
Current Cancer Drug Targets
2007
Corpus ID: 24051071
The current field of oncolytic virus development has evolved from, and been educated by, the route adenoviruses have taken to…
Expand
Highly Cited
2006
Highly Cited
2006
China approves world's first oncolytic virus therapy for cancer treatment.
K. Garber
Journal of the National Cancer Institute
2006
Corpus ID: 35337017
Oncolytic virus research got a welcome boost last November when Chinese regulators approved the world’s fi rst oncolytic viral…
Expand
Highly Cited
2004
Highly Cited
2004
[Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or…
Z. Xia
,
Jian-hua Chang
,
+14 authors
Xiao Zheng
Ai zheng = Aizheng = Chinese journal of cancer
2004
Corpus ID: 22275268
BACKGROUND & OBJECTIVE H101 is an E1B-55 kDa gene-deleted replication-selective adenovirus, which showed a significant antitumor…
Expand
Highly Cited
2001
Highly Cited
2001
Protein regions important for plasminogen activation and inactivation of α2‐antiplasmin in the surface protease Pla of Yersinia pestis
M. Kukkonen
,
K. Lähteenmäki
,
+4 authors
Timo K. Korhonen
Molecular Microbiology
2001
Corpus ID: 3211129
The plasminogen activator, surface protease Pla, of the plague bacterium Yersinia pestis is an important virulence factor that…
Expand
Highly Cited
2000
Highly Cited
2000
Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler’s virus infections
D. Theil
,
Ikuo Tsunoda
,
J. Libbey
,
T. Derfuss
,
R. Fujinami
Journal of Neuroimmunology
2000
Corpus ID: 2143196
Highly Cited
1994
Highly Cited
1994
Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells.
S. Garfinkel
,
Sondi Brown
,
J. Weßendorf
,
Thomas Maciag
Proceedings of the National Academy of Sciences…
1994
Corpus ID: 31901083
Human umbilical vein endothelial cell (HUVEC) senescence in vitro is characterized by the loss of proliferative potential and an…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE